<DOC>
	<DOCNO>NCT01596075</DOCNO>
	<brief_summary>Graft versus host disease ( GVHD ) one major cause death patient undergo allogeneic hematopoietic stem cell transplantation . Despite prophylactic measure , incidence acute GVHD estimate 40-60 % among patient receive transplant HLA-identical sibling donor , may even reach 75 % patient receive HLA-matched unrelated transplant . More effective prevention treatment strategy need . The immunomodulatory anti-inflammatory property Cannabinoids show animal model various inflammatory disease include multiple sclerosis , inflammatory bowel disease rheumatoid arthritis . Cannabidiol major non-psychoactive cannabinoid , potent anti-inflammatory immunosuppressive effect . As , may effective prevention treatment acute GVHD allogeneic stem cell transplantation .</brief_summary>
	<brief_title>Safety Efficacy Cannabidiol Grade I/II Acute Graft Versus Host Disease ( GVHD ) After Allogeneic Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<criteria>1 . Patients 18 year 2 . Acute GVHD grade I/II 3 . No history psychosis 4 . Signed informed concent 1 . Acute GVHD grade &gt; II 2 . History psychosis 3 . History asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Cannabidiol</keyword>
	<keyword>GVHD</keyword>
	<keyword>Allogeneic transplantation</keyword>
</DOC>